share_log

HC Wainwright & Co. Maintains Buy on Mainz Biomed, Lowers Price Target to $3

Benzinga ·  Mar 6 12:03

HC Wainwright & Co. analyst Yi Chen maintains Mainz Biomed (NASDAQ:MYNZ) with a Buy and lowers the price target from $5 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment